Daniele Pastori

Pubblicazioni

Titolo Pubblicato in Anno
Epicardial fat and liver stiffness by ARFI elastography in people living with Human Immunodeficiency Virus type 1 (HIV-1) infection without liver disease AIDS 2024
Neutrophil to lymphocyte ratio (NLR) and short-term mortality risk in elderly acute medical patients admitted to a university hospital emergency department INTERNAL AND EMERGENCY MEDICINE 2024
Prognostic role of serum albumin levels in patients with chronic heart failure INTERNAL AND EMERGENCY MEDICINE 2024
Inappropriate underdosing of direct oral anticoagulants in atrial fibrillation patients. results from the START2-AF registry JOURNAL OF CLINICAL MEDICINE 2024
Long-term outcomes in two-year follow-up after primary treatment in patients with a prior venous thromboembolic event. a prospective, observational, real-life study JOURNAL OF CLINICAL MEDICINE 2024
Sex-based differences in the comprehensive geriatric assessment in elderly hospitalized patients with non-valvular atrial fibrillation EUROPEAN JOURNAL OF INTERNAL MEDICINE 2024
Effects of gender affirming hormone therapy with testosterone on coagulation and hematological parameters in transgender people assigned female at birth:. a systematic review and meta-analysis THROMBOSIS RESEARCH 2024
Open Issues in the choice and management of direct oral anticoagulants in patients with cancer-related venous thromboembolism THROMBOSIS AND HAEMOSTASIS 2024
Educational attainment, obesity, and venous thromboembolism. is only matter of weight THROMBOSIS AND HAEMOSTASIS 2024
Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes. from the START antiplatelet registry SCIENTIFIC REPORTS 2024
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease HEPATOLOGY INTERNATIONAL 2024
Factor V Leiden Thrombophilia GeneReviews 2024
Incident thrombocytopenia and bleeding risk in elderly patients with atrial fibrillation on direct oral anticoagulants: insights from the ATHEROsclerosis in Atrial Fibrillation study RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS 2024
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY 2024
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence CLINICAL CHEMISTRY AND LABORATORY MEDICINE 2024
Minimizing drug-drug interactions between dabigatran and levetiracetam through clinical management: a case report EUROPEAN HEART JOURNAL. CASE REPORTS 2023
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2023
A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists JOURNAL OF CLINICAL MEDICINE 2023
Relationship between non-invasively detected liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome undergoing PCI CLINICAL RESEARCH IN CARDIOLOGY 2023

ERC

  • LS4
  • LS4_10
  • LS7
  • LS7_10

Keywords

cardiovascular disease
anticoagulation
Novel oral anticoagulants
atrial fibrillation
atherosclerosis
NAFLD
NASH
antiphospholipid antibody syndrome
ischemic heart disease
cardiovascular risk
Thrombosis
Atherothrombosis

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma